Dr. Manuel Corpas – Genomics Expert, AI Researcher & Public Figure
Dr. Manuel Corpas is a globally recognized scientist, entrepreneur, and public figure in genomics, bioinformatics, and AI-driven health data science. He has dedicated his career to advancing precision medicine, genomic diversity, and open science for the benefit of underrepresented populations.
As a pioneer in genomics, Dr. Corpas has led large-scale sequencing projects, including the Peruvian Genome Project, which expands global knowledge of human genetic diversity. His contributions to genomic data analysis, AI in bioinformatics, and health data governance have influenced public policy, industry practices, and scientific research worldwide.
Dr. Corpas is a key figure in bioinformatics innovation, developing BioJavaScript (BioJS), an open-source tool for biological data visualization, and contributing to DECIPHER, a leading platform for rare disease diagnosis used by clinicians globally.
Beyond academia, Dr. Corpas is an active public speaker, policy advisor, and advocate for open science. He is a Fellow of the Alan Turing Institute and the Software Sustainability Institute and has advised leading genomics organizations such as the Global Alliance for Genomics & Health, ELIXIR-UK, and GOBLET on ethical AI in genomics and health data governance.
His thought leadership has led to invitations to speak at high-profile events, including the UK House of Lords and the Festival of Genomics. His work has been featured in media such as Front Line Genomics, El País, and Onda Cero Radio.
Publications & Research
Dr. Corpas has authored over 80 peer-reviewed papers in genomics, AI, and bioinformatics, as well as books that explore the intersection of health, data science, and emerging technologies. His research continues to shape the field, bridging the gap between genomic data and real-world clinical solutions.
Find his latest books and research in precision medicine and bioinformatics here on Amazon.
Connect with Dr. Manuel Corpas:
Follow Dr. Corpas on social media and professional networks for updates on genomics, AI, and bioinformatics.